254 related articles for article (PubMed ID: 7504707)
1. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.
Westendorf JJ; Ahmann GJ; Armitage RJ; Spriggs MK; Lust JA; Greipp PR; Katzmann JA; Jelinek DF
J Immunol; 1994 Jan; 152(1):117-28. PubMed ID: 7504707
[TBL] [Abstract][Full Text] [Related]
2. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
Westendorf JJ; Jelinek DF
J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulatory role of CD40 in human B cell differentiation.
Splawski JB; Fu SM; Lipsky PE
J Immunol; 1993 Feb; 150(4):1276-85. PubMed ID: 7679424
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line.
Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A
Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862
[TBL] [Abstract][Full Text] [Related]
5. CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation.
Pellat-Deceunynck C; Amiot M; Robillard N; Wijdenes J; Bataille R
Cancer Res; 1996 Apr; 56(8):1909-16. PubMed ID: 8620513
[TBL] [Abstract][Full Text] [Related]
6. CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells.
Kwekkeboom J; De Boer M; Tager JM; De Groot C
Immunology; 1993 Jul; 79(3):439-44. PubMed ID: 7691726
[TBL] [Abstract][Full Text] [Related]
7. Soluble forms of CD40 inhibit biologic responses of human B cells.
Fanslow WC; Anderson DM; Grabstein KH; Clark EA; Cosman D; Armitage RJ
J Immunol; 1992 Jul; 149(2):655-60. PubMed ID: 1378075
[TBL] [Abstract][Full Text] [Related]
8. Cross-linking CD40 on human B cell precursors inhibits or enhances growth depending on the stage of development and the IL costimulus.
Larson AW; LeBien TW
J Immunol; 1994 Jul; 153(2):584-94. PubMed ID: 7517420
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD40 antibody binding modulates human multiple myeloma clonogenicity in vitro.
Tong AW; Zhang BQ; Mues G; Solano M; Hanson T; Stone MJ
Blood; 1994 Nov; 84(9):3026-33. PubMed ID: 7524765
[TBL] [Abstract][Full Text] [Related]
10. CD74 is expressed by multiple myeloma and is a promising target for therapy.
Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM
Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450
[TBL] [Abstract][Full Text] [Related]
11. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
[TBL] [Abstract][Full Text] [Related]
12. IL-4 induces conformational change of CD20 antigen via a protein kinase C-independent pathway. Antagonistic effect of anti-CD40 monoclonal antibody.
Dancescu M; Wu C; Rubio M; Delespesse G; Sarfati M
J Immunol; 1992 Apr; 148(8):2411-6. PubMed ID: 1373168
[TBL] [Abstract][Full Text] [Related]
13. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA.
Okuno Y; Takahashi T; Suzuki A; Fukumoto M; Nakamura K; Fukui H; Koishihara Y; Ohsugi Y; Imura H
Exp Hematol; 1992 May; 20(4):395-400. PubMed ID: 1568457
[TBL] [Abstract][Full Text] [Related]
14. Activated CD4+ T cells induce CD40-dependent proliferation of human B cell precursors.
Renard N; Duvert V; Blanchard D; Banchereau J; Saeland S
J Immunol; 1994 Feb; 152(4):1693-701. PubMed ID: 7509827
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of LFA-1-dependent human B-cell aggregation induced by CD40 antibodies and interleukin-4 leads to decreased IgE synthesis.
Björck P; Paulie S
Immunology; 1993 Feb; 78(2):218-25. PubMed ID: 7682536
[TBL] [Abstract][Full Text] [Related]
16. CD58 (LFA-3) stimulation provides a signal for human isotype switching and IgE production distinct from CD40.
Diaz-Sanchez D; Chegini S; Zhang K; Saxon A
J Immunol; 1994 Jul; 153(1):10-20. PubMed ID: 7515920
[TBL] [Abstract][Full Text] [Related]
17. Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells.
Chauhan D; Uchiyama H; Urashima M; Yamamoto K; Anderson KC
Stem Cells; 1995 Aug; 13 Suppl 2():35-9. PubMed ID: 8520509
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 1 autocrine growth system in human multiple myeloma.
Nagata K; Tanaka Y; Oda S; Yamashita U; Eto S
Jpn J Clin Oncol; 1991 Feb; 21(1):22-9. PubMed ID: 2067118
[TBL] [Abstract][Full Text] [Related]
19. Cross-linking of CD40 using anti-CD40 antibody, 5C11, has different effects on XG2 multiple myeloma cells.
Qi CJ; Zheng L; Zhou X; Tao Y; Ge Y; Zhuang YM; Xu Y; Yu G; Zhang XG
Immunol Lett; 2004 May; 93(2-3):151-8. PubMed ID: 15158611
[TBL] [Abstract][Full Text] [Related]
20. Expression and production of interleukin 10 in human myeloma cell lines.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
